Dr. Gary Evan Lemack, MD

Dr. Lemack practices at UT Southwestern Medical Group in Dallas, Texas.

Dr. Lemack's NPI, 1033179486, was assigned on March 27, 2006. Dr. Lemack graduated from Weill Cornell Medicine in 1991. Dr. Lemack holds Texas license K3302.

Dr. Lemack's primary practice is UT Southwestern Medical Group, at 2001 Inwood Rd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 645-0624.

Dr. Lemack's primary practice is UT Southwestern Medical Group in Dallas, Texas. Dr. Lemack is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Lemack to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lemack practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Lemack's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Lemack is board certified in female pelvic medicine and reconstructive surgery by the American Board of Urology. Dmand AI has Dr. Lemack's licenses on file in 2 states: Texas and New York.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Lemack treats.

CMS data shows 38,475 Medicare services from Dr. Lemack across 27 procedure codes in 2024, for 915 Medicare patients. Medicare paid $379,853 for them.

CMS counts 915 Medicare patients who saw Dr. Lemack in 2024. The largest group is 75 to 84, with 360 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lemack's median patient age at 68, with 47% women.

In 2024, Dr. Lemack wrote 2,444 Medicare Part D claims for 622 patients. 76% of them were for generic drugs. CMS names the drug for 2,313 of them, across 27 drugs with 11 or more claims each, at $450,152 in total drug cost. In 2023, CMS named 2,074 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Lemack for performance year 2024, reported as part of a group. Dr. Lemack accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lemack as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 140 papers to Dr. Lemack, published from 2006 to 2025. 2018 was the busiest year, with 7. The most frequent topics are Urodynamics, Urinary Incontinence, Stress and Suburethral Slings. Dr. Lemack has published most often in Urology. Dr. Lemack's most frequent co-authors are Philippe E. Zimmern, MD, Toby Chai, MD and Stephen R. Kraus, MD.

CMS Open Payments shows 423 general payments to Dr. Lemack from 30 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 57% of the total. Allergan Inc. paid the most, $57,848.

Dmand AI lists 3 awards for Dr. Lemack, most recently Regional Top Doctor in 2014.

Dr. Lemack graduated from Weill Cornell Medicine in 1991.

Dr. Lemack is in network with 22 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.